EP2885288
1,4-tvísetnar pýridasín-hliðstæður og aðferðir til meðhöndlunar á SMN-skorts-tengdum kvillum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
13.8.2013EP published:
6.10.2021EP application number:
13752768.5
EP translation filed:
7.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
12.8.2033Expiry date:
12.8.2023
Title:
1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS
Timeline
Today
13.8.2013EP application
6.10.2021EP Publication
7.12.2021Translation submitted
15.1.2022Registration published
12.8.2023Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
CHEUNG, AtwoodAddress:
Cambridge, Massachusetts 02139, US
Name:
CHIN, Donovan NoelAddress:
Cambridge, Massachusetts 02139, US
Name:
DALES, NatalieAddress:
Cambridge, Massachusetts 02139, US
Name:
FAZAL, AleemAddress:
Cambridge, Massachusetts 02139, US
Name:
HURLEY, Timothy BrianAddress:
Cambridge, Massachusetts 02139, US
Name:
KERRIGAN, JohnAddress:
Cambridge, Massachusetts 02139, US
Name:
O'BRIEN, GaryAddress:
Cambridge, Massachusetts 02139, US
Name:
SHU, LeiAddress:
Cambridge, Massachusetts 02139, US
Name:
SUN, RobertAddress:
Natick, MA 01760, US
Name:
SUNG, MooAddress:
Cambridge, Massachusetts 02139, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261682448 PDate:
13.8.2012Country:
US
Classification
Categories:
C07D 401/14, C07D 405/14, C07D 413/14, C07D 401/12, C07D 403/14, C07D 409/14, C07D 417/14, C07D 471/14, C07D 471/04, C07D 471/08, C07D 487/04, C07D 487/10, A61K 31/501, A61P 21/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 27.7.2022
Expires: 12.8.2023
Payer: Árnason Faktor ehf.